Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06220721

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

Led by Medical College of Wisconsin · Updated on 2025-05-11

618

Participants Needed

2

Research Sites

244 weeks

Total Duration

On this page

Sponsors

M

Medical College of Wisconsin

Lead Sponsor

E

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.

CONDITIONS

Official Title

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of hypertensive disorders of pregnancy including gestational hypertension, preeclampsia, eclampsia, or HELLP syndrome as per ACOG guidelines
  • Postpartum between day 0 and day 4
  • Age 18 years or older
  • Able to communicate in English or Spanish
  • Has an established obstetrician-gynecologist within the MCW or Northwestern University health system with access to electronic medical records
Not Eligible

You will not qualify if you...

  • Pre-existing hypertension before pregnancy
  • Type 1 or type 2 diabetes mellitus
  • Currently admitted to an intensive care unit at screening
  • Diagnosis of hypertensive disorders of pregnancy made during postpartum readmission after initial hospital discharge
  • Being discharged from hospital on the day of screening
  • Known allergy or contraindication to nifedipine extended-release
  • Unable or unwilling to provide informed consent
  • Currently taking long-acting antihypertensive medication for routine care
  • Maternal conditions affecting study outcomes such as sickle cell disease or systemic lupus erythematosus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

2

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

Loading map...

Research Team

A

Alyssa M Hernandez, DO

CONTACT

A

Amandla Stanley, MSN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here